Veterinary Vaccine Products

Intranasal vaccine shown to be effective for the vaccination of healthy cattle 1 week of age or older against infectious Bovine Rhinotracheitis (IBR) virus, Bovine Respiratory Syncytial Virus (BRSV) and Parainfluenza 3 virus.

Intranasal vaccine shown to be effective for the vaccination of healthy cattle 1 week of age or older against infectious Bovine Rhinotracheitis (IBR) virus, Bovine Respiratory Syncytial Virus (BRSV), Parainfluenza 3 virus, Mannheimia haemolytica and Pasteurella multocida.

Shown to be effective for the vaccination of healthy cattle 3 months of age or older against respiratory disease and abortion due to infectious bovine rhinotracheitis (IBR), respiratory disease and fetal infection, including persistently infected calves due to bovine virus diarrhea virus (BVD) Types 1 and 2, bovine respiratory syncytial virus (BRSV), parainfluenza3 virus (PI3), Mannheimia Haemolytica and Pasteurella multocida. Respiratory duration of immunity has been shown to be at least 1 year for IBR and BVD (Types 1 and 2) and at least 16 weeks for Mannheimia haemolytica and Pasteurella multocida. Reproductive duration of immunity has been shown to be at least 217 days for IBR and at least 206 days for BVD (Types 1 and 2). Duration of immunity for BRSV and PI3 has not been established. Respiratory and reproductive efficacy and duration of immunity has been demonstrated against disease caused by the BVD Type 1b strain.

Intranasal vaccine shown to be effective for the vaccination of healthy cattle 1 week of age or older against Mannheimia haemolytica and Pasteurella multocida.

Shown to be effective for the vaccination of healthy cattle 3 months of age or older against respiratory disease and abortion due to infectious bovine rhinotracheitis (IBR), respiratory disease and fetal infection, including persistently infected calves due to bovine virus diarrhea virus (BVD) Types 1 and 2, bovine respiratory syncytial virus (BRSV) and parainfluenza3 virus (PI3). Respiratory and reproductive efficacy and duration of immunity has been demonstrated against disease caused by the BVD Type 1b strain.

Shown to be effective for the vaccination of healthy cattle 3 months of age or older against disease caused by Pasteurella multocida and Mannheimia haemolytica.

Shown to be effective for the vaccination of healthy cattle, sheep and goats against disease caused by Clostridium perfringens Types C and D (Enterotoxemia) and Cl. tetani (Tetanus).

Shown to be effective for the vaccination of healthy cattle and sheep against disease caused by Clostridium chauvoei, C. septicum, C. novyi Type B, C. haemolyticum (known also as C. novyi Type D), C. tetani and C. perfringens Types C and D.

Shown to be effective for the vaccination of healthy cattle and sheep against disease caused by Clostridium chauvoei (Blackleg), Cl. septicum (Malignant edema), Cl. haemolyticum (Bacilliary Hemoglobinuria (Red water)), Cl. novyi (Black disease), Cl. sordellii and Cl. perfringens Types C and D (Enterotoxemia).

Shown to be effective for the vaccination of healthy cattle against disease caused by Clostridium chauvoei, Cl. septicum, Cl. haemolyticum, Cl. novyi, Cl. sordellii, Cl. perfringens Type C and D, and Histophilus somni.

Shown to be effective for the vaccination of healthy cattle against disease caused by Clostridium chauvoei (Blackleg), Cl. septicum (Malignant edema), Cl. novyi (Black disease), Cl. sordellii, Cl. perfringens Types C and D (Enterotoxemia), and Histophilus somni.

Shown to be effective for the vaccination of healthy cattle 3 months of age or older against disease caused by Clostridium chauvoei, Cl. septicum, Cl. novyi Type B, Cl. haemolyticum, Cl. sordellii, Cl. tetani and Cl. perfringens Types C and D.

Shown to be effective for the vaccination of healthy cattle and sheep against disease caused by Clostridium chauvoei (Blackleg), Cl. Septicum (Malignant edema), Cl. novyi (Black disease), Cl. sordellii, Cl. perfringens Types C and D (Enterotoxemia).

Multiple-antigen product shown to be effective for the vaccination of healthy pregnant cattle to provide passive immunity against neonatal calf diarrhea caused by enterotoxigenic E. coli pilus type K99, bovine Group A Serotype G6 and G10 rotaviruses, bovine coronavirus types 1 and 3, and enterotoxemia caused by Cl. perfringens Types C and D.

Intranasal vaccine shown to be effective for the vaccination of healthy calves against enteric disease caused by bovine coronavirus. Efficacy shown in calves 3 days of age and older. Safety has been shown in calves 1 day of age and older.

Shown to be effective for the vaccination of healthy cattle against L. canicola, L. grippotyphosa, L. hardjo including L. borgpetersenii serovar hardjo bovis, L. icterohaemorrhagiae, and L. pomona and reproductive disease caused by Campylobacter fetus. Effective against urinary shedding of hardjo bovis organisms.

Shown to be effective for the vaccination of healthy cattle 6 months of age or older against L. canicola, L. grippotyphosa, L. hardjo including L. borgpetersenii serovar hardjo bovis, L. icterohaemorrhagiae, and L. pomona. Effective against urinary shedding of hardjo bovis organisms.

Shown effective for the vaccination of healthy cattle 6 months of age or older against respiratory disease and abortion due to infectious bovine rhinotracheitis (IBR), respiratory disease and fetal infection, including persistently infected calves due to bovine virus diarrhea virus (BVD) Types 1 & 2, bovine respiratory syncytial virus (BRSV) and parainfluenza3 virus (PI3) and leptospirosis (caused by Leptospira canicola, L. grippotyphosa, L. hardjo – including the L. borgpetersenii serovar hardjo bovis, L. icterohaemorrhagiae, and L. pomona). Effective against urinary shedding of hardjo bovis organisms. Respiratory and reproductive efficacy and duration of immunity has been demonstrated against disease caused by the BVD Type 1b strain.

Shown effective for the vaccination of healthy cattle 6 months of age or older against respiratory disease and abortion due to infectious bovine rhinotracheitis (IBR), respiratory disease and fetal infection, including persistently infected calves due to bovine virus diarrhea virus (BVD) Types 1 & 2, bovine respiratory syncytial virus (BRSV) and parainfluenza3 virus (PI3), reproductive disease caused by Campylobacter fetus and leptospirosis (caused by Leptospira canicola, L. grippotyphosa, L. hardjo – including the L. borgpetersenii serovar hardjo bovis, L. icterohaemorrhagiae, and L. pomona). Effective against urinary shedding of hardjo bovis organisms. Respiratory and reproductive efficacy and duration of immunity has been demonstrated against disease caused by the BVD Type 1b strain.

Shown to be effective for the vaccination of healthy cattle 3 months of age or older against respiratory disease and fetal infection, including persistently infected calves caused by bovine diarrhea virus (BVD) Types 1 & 2. Respiratory and reproductive efficacy and duration of immunity has been demonstrated against disease caused by the BVD Type 1b strain.

Shown to be effective for the vaccination of healthy cattle against disease caused by Clostridium chauvoei (Blackleg), Cl. septicum (Malignant edema), Cl.novyi (Black disease), Cl. sordellii and Cl. perfringens Types C and D (Enterotoxemia) and Moraxella bovis (Pinkeye or infectious bovine keratoconjunctivitis).

Shown to be effective for the vaccination of healthy cattle against pinkeye caused by Moraxella bovis strains expressing pili similar to those expressed by isolates referred to by Merck Animal Health as strains Epp 63, Fla 64 and SAH 38.

Shown to be effective for the vaccination of healthy cattle against pinkeye caused by Moraxella bovis strains expressing pili similar to those expressed by isolates referred to by Merck Animal Health as strains EPP 63, FLA 64 and SAH 38, and against diseases caused by Clostridium chauvoei, Cl. septicum, Cl. Novyi Type B, Cl. sordellii and Cl. perfringens Types C and D. Immunity is also provided against Cl. perfringens Type B.

Gram-negative infections from bacteria like Escherichia coli cause mastitis that leads to milk loss, culling and death. BOVILIS® J-5 is a Gram-negative core-antigen vaccine that aids in the reduction of mastitis due to E. coli – with the lowest level of endotoxins to minimize potential side effects.